Michels, Sebastian ;
Massuti, Bartomeu ;
Schildhaus, Hans-Ulrich...
Michels , S , Massuti , B , Schildhaus , H-U , Franklin , J , Sebastian , M , Felip , E , Grohe , C , Rodriguez-Abreu , D , Abdulla , D S Y , Bischoff , H , Brandts , C , Carcereny , E , Corral , J , Dingemans , A-M C , Pereira , E , Fassunke , J , Fischer , R N , Gardizi , M , Heukamp , L , Insa , A , Kron , A , Menon , R , Persigehl , T , Reck , M , Riedel , R , Rothschild , S I , Scheel , A H , Scheffler , M , Schmalz , P , Smit , E F , Limburg , M , Provencio , M , Karachaliou , N , Merkelbach-Bruse , S , Hellmich , M , Nogova , L , Buettner , R , Rosell , R & Wolf , J 2019 , ' Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS) : A European Phase II Clinical Trial ' , Journal of Thoracic Oncology , vol. 14 , no. 7 , pp. 1266-1276 . https://doi.org/10.1016/j.jtho.2019.03.020.
,
2019
